Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

Table 1

Estimated cumulative probabilities with 95% confidence interval of ADA development before 18 months of IFNβ therapy.

Table 1

doi: https://doi.org/10.1371/journal.pone.0162752.t001